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Abstract Substrates coated with specific bioactive
ligands are important for tissue engineering, enabling the
local presentation of extracellular stimulants at controlled
positions and densities. In this study, we examined the
cross-talk between integrin and epidermal growth factor
(EGF) receptors following their interaction with surface-
immobilized Arg-Gly-Asp (RGD) and EGF ligands,
respectively. Surfaces of glass coverslips, modified with
biotinylated silane-polyethylene glycol, were functional-
ized by either biotinylated RGD or EGF (or both) via the
biotin–NeutrAvidin interaction. Fluorescent labeling of the
adhering A431 epidermoid carcinoma cells for zyxin or
actin indicated that EGF had a dual effect on focal adhe-
sions (FA) and stress fibers: at low concentrations (0.1;
1 ng/ml), it stimulated their growth; whereas at higher
concentrations, on surfaces with low to intermediate RGD
densities, it induced their disassembly, leading to cell
detachment. The EGF- dependent dissociation of FAs was,
however, attenuated on higher RGD density surfaces.
Simultaneous stimulation by both immobilized RGD and
EGF suggest a strong synergy between integrin and EGFR
signaling, in FA induction and cell spreading. A critical
threshold level of EGF was required to induce significant
variation in cell adhesion; beyond this critical density, the
immobilized molecule had a considerably stronger effect
on cell adhesion than did soluble EGF. The mechanisms
underlying this synergy between the adhesion ligand and
EGF are discussed.
1 Introduction
This study focuses on the cross-talk between an adhesive
(RGD) and a signaling (EGF) molecule, and its impact on
cell–matrix adhesion. RGD is a known adhesion peptide,
which has been introduced into cells in an immobilized
form [1]. EGF is a growth factor present in a soluble form.
It has been shown that the EGF receptor (EGFR) and its
downstream signaling cascade are activated only when
integrin receptors are aggregated and activated by their
respective adhesion ligands [2]. The cross-talk between
these two ligand-receptor systems also affects the reci-
procal process; namely, integrin-mediated adhesion [3–5].
Thus, the addition of soluble EGF to the epidermoid car-
cinoma cells, A431 and other cell types resulted in the
formation of aligned actin stress fibers [3, 6–8]. Live-cell
imaging and electron microscopy have revealed major
cytoskeletal rearrangements in EGF-treated A431 cells,
manifested by extensive lamellipodia and filopodia exten-
sion, and induction of membrane ruffling [7, 9]. In some
studies, growth and elongation of focal adhesions along
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actin stress fibers following soluble EGF stimulation was
reported in fibroblasts and other cell types [5, 10, 11]. In
contrast, other studies have suggested that EGF-mediated
signaling promotes structural cytoskeletal changes which
lead to cell polarization, the generation of intercellular
contractile forces [6], and partial disassembly of focal
adhesions, that eventually promote cell migration [8].
The spatial distribution of cell-surface receptors for the
extracellular matrix (ECM), as well as of a variety of
growth factors, has a major influence on their activation
and function. For example, cell adhesion to the matrix
induces the clustering of transmembrane integrins into
actin-associated focal adhesions (FA) [12, 13]. Further
recruitment of multiple scaffolding and signaling ‘‘adhe-
some’’ molecules, such as vinculin, talin, zyxin and focal
adhesion kinase (FAK) [14] play a central role in regulat-
ing the ECM adhesion process, as well as its subsequent
regulation of cell survival, division and differentiation
[14–17]. Similarly, the EGF-induced, autophosphorylation-
driven clustering of epidermal growth factor receptors
(EGFR), is essential for the activation of the relevant
downstream signaling cascades [18–20].
The immobilization of different types of effectors’
molecules to a surface has been found to be critical for
controlling their effect on cell behavior. For example, an
integrin-dependent spreading, polarization and migration
of dendritic cells was found to be induced by immobilized
but not soluble CC21 (a chemokine for CC-chemokine
receptor 7) [21]. Similarly, surface-immobilized EGF has
been shown to be particularly effective in inducing cell
survival [22], proliferation [17, 23] and differentiation [24]
of various cell types. For example, surface-tethered EGF
was considerably more effective than soluble EGF in
promoting mesenchymal stem cell (MSC) spreading and
survival [22]; neurogenic differentiation of pheochromo-
cytoma (PC12) cells occurred with immobilized EGF, but
not with soluble growth factor. This finding relates to the
long-lasting duration of the stimulation compared to that of
the soluble molecules, which were degraded via receptor-
mediated endocytosis [24].
In addition, this hyperactivity of surface-bound EGF
raised the possibility that the EGFR might affect, and be
affected by, matrix adhesion molecules such as integrins.
This notion has so far attracted only scant attention; it has,
however, been shown that the response of cells to soluble
EGF depends on the surface densities of fibronectin and
collagen, which affected the adhesion and motility of
various cell types [5, 25, 26]. Recently, Elloumi et al. [27]
showed that human lung carcinoma epithelial cells retained
their adhesiveness and growth activity when plated on
culture plates coated with a protein complex containing
both RGD and EGF molecules, conjugated by a hydro-
phobic protein. Yet the mechanism underlying the synergy
between integrins and EGFR remains largely unknown. For
example, it is still unclear whether EGF affects FAs in a
general manner, or whether it involves local cross-talk
between the EGFR and the integrin-mediated adhesions.
This issue; namely, the exact site of action of growth factor
receptors, is potentially important for the fabrication of
implants to be used in tissue engineering and regenerative
medicine [28].
To study the mechanism underlying EGFR-integrin
cooperation, we functionalized glass surfaces with biotin-
NH-CH2-CH2(O-CH2-CH2)n-NHCONH(CH2)3-Si(OEt)3
(silane-PEG-biotin). This polymer contains a PEG back-
bone, known for its non-adhesive properties [29–32], and
terminated with a biotin molecule. Biotin displays a strong
affinity for avidin, streptavidin and NeutrAvidin (Kd of
10-15 M-1), and is also highly specific [33]. Biotin-ter-
minated PEG has previously been anchored to surfaces
using a variety of chemistries, including electrostatic
attachment via positively-charged lysine groups [34], the
adhesive amino acid DOPA [35], and attachment to reac-
tive self-assembled silane layers [36, 37]. The single–step
silane-anchoring approach used here has been shown to
produce a surface that repels most proteins, but can be
functionalized with streptavidin [29]. We modified the
biotin-functionalized surfaces using NeutrAvidin–biotin-
modified RGD/EGF complexes at varying concentrations,
thus obtaining surfaces functionalized with RGD alone, or
with RGD and EGF, at different densities (schematic pre-
sentation in Fig. 1). Next, we tracked the adhesion and
spreading patterns of A431 cells as a function of the rela-
tive densities of immobilized RGD and EGF. We then
compared the cell adhesion response to surface-immobi-
lized EGF, with the response to soluble EGF; namely, the
response to local stimulation, at adhesion sites versus
global stimulation, respectively.
We show here that EGF and RGD can exhibit either
positive or negative cooperativity. Thus, EGF can act either
as an adhesion enhancer or an adhesion suppressor,
depending on: (a) EGF quantities, (b) RGD density,
(c) mode of application, soluble or immobilized, and
(d) duration of application. For example, when EGF was
applied in a soluble form for 30 min, 5 h after cell plating,
it behaved as an adhesion stimulator up to a certain con-
centration, above which it led to cell detachment. The
threshold detachment concentration was dependent on
the RGD density: the higher the RGD density, the higher
the inhibitory threshold concentration. Moreover, on high
RGD density surfaces, immobilized EGF enhanced adhe-
sion more strongly than soluble EGF (as manifested by an
increase in the number of FAs) up to 164.9 ± 42.3 pmol/
cm2 at which cell detachment was observed with immo-
bilized EGF, but not with soluble EGF. A significant cell
adhesion response was obtained at an EGF density of
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3.8 ± 1.4 pmol/cm2, and pronounced differences between
the cellular response to global and local EGF stimulation
were observed above this density. These cellular behaviors
may be due to the physical proximity of the activated
EGFR to RGD-anchored integrins, and the apparent syn-
ergism between these two receptor systems.
2 Experimental
2.1 Biotinylation of Proteins
The c[RGDfK] [3–5], modified at the Lys side chain by a
short biotin-oligo(EG)6 linker (biotin-RGD, Fig. 1), was
custom-synthesized by Biosyntan, (Berlin, Germany).
Biotin-conjugated murine EGF (PeproTech Inc., Rocky
Hill, NJ, USA) was prepared using an amine-reactive biotin
labeling reagent with a long polyethylene glycol (PEG)
spacer arm (56 A˚), N-hydroxysuccinimid (NHS)-CO-
(O-CH2-CH2)12-NHCO(CH2)4-biotin (NHS-PEG12-biotin,
Fig. 1). The N-hydroxysuccinimide ester (NHS) group
reacts specifically and efficiently with primary amines
found in lysine and N-terminal amino groups, to form
stable amide bonds. We chose to biotinylate murine- rather
than human EGF, since murine EGF does not contain
lysines in its structure, and hence displays an amine-reac-
tive group only at its N-terminus, so that the protein’s
activity is not affected by the biotin modification. The non-
reactive biotinylation reagent was separated from the bio-
tinylated protein using Zeba Spin Desalting columns;
the protein biotinylation efficiency was determined by a
Quantitation Kit. All the latter products were purchased
from Thermo Fisher Scientific Pierce Biotechnology,
Rockford, Illinois, USA. The effect of soluble mouse-biotin
Fig. 1 A schematic
presentation of RGD and EGF
surface functionalization.
Plasma -etched glass slides
(a) are incubated with
triethoxysilane–PEG–biotin in
toluene, resulting in the
formation of biotinylated glass
slides (b). The biotinylated glass
slides are further incubated with
preformed NeutrAvidin
(NT)–biotin–EGF/RGD
complexes at various complex
concentrations, resulting in the
formation of glass cover slips
biofunctionalized with RGD
(c) or with a mixture of RGD
and EGF at different densities
and ratios (d)
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EGF on A431 FAs was similar to that of human EGF
(Figs. 3d, 5e).
2.2 Preparation of Substrates
Specifically functionalized monolayers were prepared
and stored under argon, using biotin-NH-CH2-CH2(O-CH2-
CH2)n-NHCONH(CH2)3-Si(OEt)3 (silane-PEG-biotin);
((O-CH2-CH2)n section has Mw = 2,000 Da; Fig. 1), a
custom synthesis obtained from Rapp Polymere GmbH
(Tu¨bingen, Germany) according to a procedure previously
described (24). Glass coverslips 60 9 24 mm #1 (Mari-
enfeld, Lauda- Konigshofen, Germany) were cleaned
with Hellmanex 2% detergent (Hellma GmbH, Mullheim,
Germany) for 45 min, then thoroughly rinsed with water,
ethanol and acetone, dried at 80C, and then treated for
5 min with air plasma in a Plasma Cleaner/Sterilizer PDC-
32G (Harrick Scientific, Ossining, NY, USA). This pro-
cedure was conducted in order to remove any organic
contaminants, and create hydroxyl groups on the glass
surface. The plasma-treated substrates were immediately
inserted into a flask connected to a stream of nitrogen. To
form self-assembled monolayers, dry toluene (60 ml,
[99.9% purity) (Merck KGaA, Darmstadt, Germany),
dried with molecular sieves, was added to the flask con-
taining the substrate, followed by triethylamine (Sigma-
Aldrich, Seelze, Germany), milliQ water (0.1% of the
toluene volume) and silane–PEG–biotin (3–5 mg). The
flask was then sealed and incubated at 80C for 12 h, after
which the substrates were washed with ethyl acetate (Ga-
dot, Herzlia, Israel) and methanol (Biolab, Jerusalem,
Israel) and then dried under a stream of nitrogen. All sol-
vents were analytical grade. The formation of pure,
homogenous monolayers of silane-PEG-biotin was shown
by Kartos AXIX-HS XPS (Fig. S1, Supplementary
Information).
The silane–PEG–biotin-modified slides were mounted
onto the bottom of a Flexiperm silicon gasket (Sastedt,
Numbrecht, Germany), dividing the slide into 12 separate
wells of 5 mm diameter each. NeutrAvidin (Thermo Fisher
Scientific Pierce Biotechnology)–biotin–RGD/EGF com-
plexes at a 1:2 ratio were pre-formed by incubation at room
temperature. Surfaces presenting RGD or a combination of
RGD and EGF, at various densities, were formed by
incubating the silane–PEG–biotin glass slides with various
concentrations of the NeutrAvidin–biotin–RGD complex in
PBS, or a mixture of NeutrAvidin–biotin–RGD/EGF
complexes in PBS for 30 min at 37C, as indicated in the
results section (Fig. 1).
The application of 0.1 mg/ml DyLight488-labeled
NeutrAvidin (Thermo Fisher Scientific Pierce Biotechnol-
ogy, Rockford, United States) has resulted in surface sat-
uration with the protein (Fig. S2, Supplementary
Information). The spacing between adjacent biotin groups
on the silane–PEG–biotin -modified glass surface was
calculated to be 4.6 nm, based on XPS measurements (Fig.
S1, Supplementary Information). Since the cross-section of
NeutrAvidin is about 4.5 nm, this surface density of biotin
is enough to induce surface saturation with NeutrAvidin.
The density of NeutrAvidin–biotin–EGF complex bound
to the biotinylated surface was determined by the gamma-
irradiation of I125- labeled biotin-EGF. A graph showing
the density of surface- adsorbed NeutrAvidin–biotin–EGF-
I125 as a function of the concentration of the applied
solution is shown in Fig. S3, Supplementary Information.
The amount of surface-immobilized NeutrAvidin–biotin–
EGF complex was not significantly affected by the con-
centration of NeutrAvidin–biotin–RGD complex applied in
the same solution, since the surface coverage was well
below saturation for all concentrations used (Fig. S3,
Supplementary Information). Since both RGD and EGF are
much smaller than a NeutrAvidin molecule (0.9, 6.4 and
60 kDa, respectively) the surface coverage for a given
solution concentration can be taken to be the same for
NeutrAvidin–biotin–RGD as for NeutrAvidin–biotin–EGF.
Hence, the density of NeutrAvidin–biotin–RGD was cal-
culated from the gamma radiation of NeutrAvidin–biotin–
EGF- I125.
2.3 Cell Culture
A431 epidermoid carcinoma cells from the American Type
Culture Collection (ATCC) (Manassas, VA, USA) were
chosen due to the high number of EGF receptors expressed
on their surface (3 9 106/cell). Cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal calf serum, and regularly replated
by a treatment with trypsin–EDTA solution. Tissue culture
medium, fetal calf serum, trypsin–EDTA, penicillin–
streptomycin and sodium pyruvate solutions were obtained
from Gibco (Gibco Company, Carlsbad, CA, USA). Cells
were maintained at 37C in a humidified incubator, under
5% CO2.
2.4 Cell Adhesion Assay
A431 cells were grown to *70% confluence, and serum-
starved for 12 h in DMEM containing 1% bovine serum
albumin (BSA) fraction V (Serva Electrophoresis GmbH,
Heidelberg, Germany), 1% sodium pyruvate, and 1%
penicillin–streptomycin. The starved A431 cells were
harvested by trypsin–EDTA, plated at a density of
7.5 9 104 cells/cm2 in the same serum-free medium on
either RGD or on both RGD- and EGF-functionalized
surfaces, and incubated for 5 h, the amount of time needed
for the A431 cells to adhere and fully spread on the
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functionalized surfaces. Following the incubation period,
cells plated on RGD functionalized surfaces were exposed
to various concentrations of soluble human EGF (Sigma-
Aldrich Israel, Ltd., Rehovot, Israel) for 30 min, and then
fixed and stained for zyxin and actin. Cells plated on sur-
faces functionalized with both RGD and murine EGF were
fixed and stained directly after the incubation period. To
compare cellular responses to stimulation by immobilized
and soluble murine biotin-EGF stimulation, equal numbers
of either soluble or immobilized molecules were intro-
duced into each well. Soluble murine biotin-EGF was
added immediately after cells were plated on surfaces
modified with RGD only, allowing a total of 5 h incubation
with the soluble molecule.
2.5 Immunochemical Reagents and Indirect
Immunofluorescence
For the staining of focal adhesions and actin filaments, cells
cultured on the functionalized surfaces were fixed and
permeabilized for 5 min in 3% paraformaldehyde (PFA)
containing 0.5% Triton X-100 (Sigma-Aldrich Ltd., Reho-
vot Israel), and then further fixed with 3% paraformalde-
hyde in PBS for 30 min. Triple-labelling for visualization of
focal adhesions, the actin cytoskeleton, and nuclei was
achieved by incubating cells with zyxin primary rabbit
antibodies (B71/72, kindly provided by Mary Beckele,
University of Utah, [38]), and a mixture of goat anti-rabbit
Cy3 (Jackson ImmunoResearch, West Grove, PA, USA),
TRITC-labeled phalloidin, and DAPI (Sigma-Aldrich, St.
Louis, MO, USA).
2.6 Microscopy and Image Analysis
Microscopic imaging was conducted using a WiScan
automated microscope (Idea Bio-Medical, Ltd., Rehovot,
Israel). Images of fluorescently-stained cells were acquired
with a 609/0.90 NA Olympus objective, Olympus Europa
GmbH, Hamburg, Germany, and analyzed using Prism
software. The acquired images in each well were tiled into
montages, to give an overall visual impression of the cells,
while still maintaining the full resolution of the individual
images. Specific features of focal adhesions—FA area, FA
elongation (aspect ratio), and number of FAs per cell—were
calculated, as previously described by Paran et al. [39]. In
brief, high-pass filtered images are first segmented, using a
WaterShed threshold algorithm [40, 41], and for each FA,
morphological, fluorescence-intensity, and estimated
background parameters are calculated. Object-by-object,
multiparameter data for each image were saved in separate
files. User-controlled ranges for each parameter (kernel size
for the high pass filter, minimum and maximum object size,
threshold gates) defined the objects to be included in the
montage, and the outliers to be excluded.
Values of the parameters characterizing cell morphol-
ogy—cell elongation (aspect ratio of best-fit ellipse) and
cell projection area were determined using Image J
software.
2.7 Data Analysis
The statistical distribution of the morphological FA and
cell parameters was not a normal Gaussian distribution and
hence, the values of these parameters were primarily based
on the 70th or 90th percentile values calculated for each
parameter, as indicated (i.e., the parameter values below
which 70 or 90% of all cells/FAs are found). Cell shape and
FA parameters were measured in at least 80 individual cells
for each experimental treatment. Each experiment was
repeated at least three times.
3 Results and Discussion
3.1 RGD Density Affects Cell Attachment
and Spreading
It was shown that integrin clustering is essential for cell-
surface attachment, spreading and FA formation [12, 13];
hence, attachment and spreading of A431 epidermoid
carcinoma cells were investigated on surfaces functional-
ized with varying RGD densities. Figure 2 shows that
A431 spreading and polarization varies greatly, depending
on RGD surface density. At low RGD densities
(6–12 pmol/cm2) cells attached to the surface but failed to
spread, and in many cases were more elongated in shape,
whereas at high RGD densities (23–184 pmol/cm2 RGD),
cells were well spread with peripheral actin bundles. A
similar range of RGD density was required for the for-
mation of cells with well-formed stress fibers on star
polymers presenting RGD [26]. Surfaces modified with
only silane–PEG–biotin or with silane–PEG–bio-
tin ? NeutrAvidin without biotin-RGD, were completely
inert to cell adhesion.
3.2 Soluble EGF Induces FA Growth
It was previously shown that the addition of EGF to the
growth medium of serum-starved cells results in a signifi-
cant growth of FAs, and the associated actin stress fibers
[10]. Similarly, A431 cells plated on high-density RGD or
FN surfaces in serum-free medium formed only small FAs
in the absence of EGF; yet application of increasing con-
centrations of soluble EGF resulted in a major increase in
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FA aspect ratio and area (Fig. 3a, c) as well as in the
formation of actin cables (Fig. 3d).
Low EGF concentrations, of up to 1 ng/ml, induced a
notable increase in the number of elongated FAs (Fig. 3b,
d) and actin stress fibers. At higher EGF concentrations (10
and 100 ng/ml), FAs were fewer, larger and more elon-
gated; in many such cells, extensive formation of filopodia,
accompanied by extensions of actin-containing micro-
spikes and formation of dense actin stress fibers was seen
(Fig. 3d, for 10 ng/ml). The FAs were routinely monitored
by zyxin labeling, as focal adhesion marker [42, 43],
though essentially the same behavior was observed using
paxillin and vinculin labeling (data not shown).
3.3 RGD Density Affects Cell Response to Soluble
EGF
To explore the mechanism underlying the effect of EGF on
FAs, we systematically modulated both EGF concentration
in the medium, and RGD density on the substrate, and
examined the cellular responses.
The addition of up to 1 ng/ml soluble EGF to A431
cells, plated on RGD surfaces, led to an increase in the
number of FAs per cell (Fig. 4a, b). The number of FAs per
cell also increased, with an increase in RGD surface den-
sity; this effect was most pronounced at an EGF concen-
tration of 1 ng/ml (Fig. 4a). Cell exposure to higher EGF
concentrations, however, (10 and 100 ng/ml EGF) resulted
in either cell rounding and detachment from the surface, or
in strongly attached cells slightly fewer in total number, but
with more elongated FAs. These two scenarios depended
on the RGD surface density: at low to intermediate RGD
densities, cells rounded and detached from the surface (low
bars with dashed border in Fig. 4a) and at high RGD
densities, cells remained stable, with slightly more elon-
gated FAs. Interestingly, cells rounded and detached from
Fig. 2 A431 cell spreading on RGD-biofunctionalized surfaces at
varying densities. The fluorescent images in the top panel are of actin-
labeled A431 cells; the numbers on each image indicate the RGD
density in pmol/cm2 (a), scale bar 15 lm. The graphs in the bottom
panel display the 90th percentiles of cell aspect ratio (b) and cell area
(c). All results are expressed as mean ± confidence intervals (CI).
Aspect ratio and area of cells plated on 6 and 12 pmol/cm2 RGD
surfaces that significantly differed from 46 pmol/cm2 RGD surfaces
at the P-value levels P \ 0.05 and P \ 0.01 are denoted by one and
two asterisks, respectively
Fig. 3 Focal adhesion growth and actin filament reorganization in
A431 cells exposed to soluble EGF. Cells were plated on surfaces
modified with 184 pmol/cm2 RGD. Five hours after cell plating, EGF
was added to the medium for 30 min. A separate cell sample was
incubated for 5.5 h without EGF, as a control. After 5.5 h, both
samples were fixed and stained for zyxin at focal adhesions and for
actin filaments. The graphs in the top panel indicate the 90th
percentile of the focal adhesion elongation (a), the average number of
focal adhesions per cell (b), and area (c) as a function of EGF
concentration. All results are expressed as mean ± confidence
intervals (CI). Parameters of FAs in cells that were exposed to
soluble EGF and significantly differed from the corresponding
parameters of FAs in control cell, not exposed to EGF, at the P-value
levels P \ 0.05 and P \ 0.01 are denoted by one and two asterisks,
respectively. Fluorescent images of actin- and zyxin-labeled cells
exposed to 1 and 10 ng/ml, in comparison to control (no EGF) are
presented in the bottom panel (d). Scale bar 15 lm
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23 and 46 pmol/cm2 RGD surfaces, but remained strongly
attached to 92 and 184 pmol/cm2 RGD surfaces, when
100 ng/ml EGF was added, despite the fact that at these
RGD densities, cell spreading was quite similar, in the
absence of EGF (Fig. 2).
Figure 4a (insert) shows the number of FAs plotted as a
function of the surface RGD density. The maximum pos-
sible number of FAs per cell is determined by the EGF
concentration. This is indicated by the plateau reached at a
threshold RGD density of 46 pmol/cm2 RGD, which was
not affected by EGF concentration.
3.4 Cell Adhesion in Response to Global or Local EGF
Stimulation
The effect of the mode of receptor stimulation (i.e., global
or local) on the synergy between integrin and EGFR was
investigated by tracking the cells’ adhesive response to
surface-bound EGF in comparison to soluble EGF, as a
function of the RGD and EGF densities.
Figure 5 indicates that the effect of soluble or immo-
bilized EGF on cell adhesion was significant only at a
certain threshold level: At a minimal amount of EGF
[(0.75 ± 0.28) 9 103 fmol] cells become significantly
smaller and more round regardless of whether the EGF was
soluble or immobilized (Fig. 5b, c). However, the effect of
immobilized EGF on cell adhesion differed greatly from
that of soluble EGF above this threshold EGF amount:
Cells were plated on RGD surfaces and 21.4 ± 5.3
pmol/cm2 [(4.19 ± 1.04) 9 103 fmol] immobilized EGF
displayed a significant increase in the number of FAs per
cell and in cell spreading (with the projected cell area
returning to the same value as that seen in the absence of
EGF; for non- treated cells) (Fig. 5a, b). In contrast, cells
plated on RGD-only surfaces, exposed to the same level of
EGF in soluble form, showed only a slight increase in the
number of FAs per cell and a further reduction in cell
spreading (Fig. 5a, b). A further increase in the level of
immobilized EGF resulted in loss of FAs and cell detach-
ment. However, treatment with the same level of soluble
EGF did not lead to cell detachment; indeed, some FAs
remained (Fig. 5a, d). With both forms of stimulation, FAs
became more elongated as EGF levels increased, while
cells became more round (Fig. 5d).
The immobilization of EGF also had a profound effect
on the arrangement and density of actin stress fibers. Cells
that spread on 46 pmol/cm2 RGD surfaces in the absence
of EGF displayed actin stress fibers at the cell periphery,
and only a few filopodia. As EGF levels increased, more
actin stress fibers across the cell were observed, accom-
panied by an increase in filopodia and actin-containing
microspikes (Fig. 5d). The increase in actin stress fibers
and actin-containing filopodia and microspikes was by far
more significant at the immobilized-EGF density
(21.4 ± 5.3 pmol/cm2 or (4.19 ± 1.04) 9 103 fmol) than
at the same level of soluble EGF. In addition, cells plated
on immobilized EGF at this density adopted a large, pan-
cake-like shape with extended lamellipodia containing
Fig. 4 The effect of RGD density on cell adhesion in response to
soluble EGF. Average number of focal adhesions per cell as a
function of EGF concentration on surfaces with different RGD
densities (a), the numbers at the top right of the graphs are the RGD
density in pmol/cm2. Low bars with dashed borders represent a
scenario where cells detached from the surface. The insert in a, at the
top left represents the same data as that seen in the main graph, where
the average number of focal adhesions per cell are plotted as a
function of the surface RGD density. The numbers at the top of each
graph represent the applied EGF concentrations in ng/ml. All results
are expressed as mean ± confidence intervals (CI). Number of FAs in
cells plated on 46, 92 and 184 pmol/cm2 RGD surfaces that were
significantly higher than the number of FAs in cells plated on both 6
and 12 pmol/cm2 RGD surfaces at the P-value levels P \ 0.05 and
P \ 0.002 are denoted by one and two asterisks, respectively. The
images in the bottom panel are of A431 cells, plated on surfaces
modified with RGD at different densities, following stimulation with
1 ng/ml EGF. The number on each image indicates the RGD density
in pmol/cm2. The experimental procedure was the same as that
described in the legend to Fig. 3. Scale bar 15 lm
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Fig. 5 A comparison between cell response to immobilized and
soluble EGF as a function of RGD density and total EGF amounts.
For comparison, the amounts of immobilized and soluble EGF are
calculated for the given well area or the given volume, respectively.
The 70th percentile of the cell area (b) and cell aspect ratio (c) are
summarized for cells plated on either 12 (dashed line) or 46 (solid
line) pmol/cm2 RGD-modified surfaces as a function of the amount of
immobilized (Imm dark circles) or soluble (Sol empty diamond) EGF.
The average numbers of focal adhesions per cell as a function of EGF
are presented for cells plated on 46 pmol/cm2 RGD surfaces (a). All
results are expressed as mean ± confidence intervals (CI). Number of
FAs per cell or cell area for cells plated on 46 pmol/cm2 RGD
surfaces and (4.19 ± 1.04) 9 103 fmol immobilized EGF that were
significantly different from the same parameters of cells exposed to
the same amount of soluble EGF at the P-value level P \ 0.05 are
denoted by one asterisks. This mark also indicate the P value level for
the differences between the parameters of cells plated on (0.75 ±
0.28) 9 103 and (4.19 ± 1.04) 9 103 fmol immobilized EGF. Aspect
ratio of cells plated on 12 or 46 pmol/cm2 RGD surfaces and
(4.19 ± 1.04) 9 103 fmol immobilized EGF differed from cells
plated on RGD only surfaces at a P-value of P \ 0.05 (*) and
P \ 0.01 (**), respectively. Bottom panel images of zyxin- and actin-
labeled A431 cells, plated on surfaces modified with 46 pmol/cm2
RGD and various amounts of immobilized (d) or soluble EGF (e).
Cells were incubated on the different surfaces for 5 h, and then fixed
and stained for zyxin and actin. Scale bar 15 lm
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short stress fibers, probably responsible for the marked
increase in cell area.
The difference between stimulation with soluble and
immobilized EGF was also RGD density-dependent: the
differences in cell spreading above a critical EGF level
were observed only on surfaces with high RGD densities
(23 and 46 pmol/cm2 RGD), but not on surfaces with low
RGD densities (6 and 12 pmol/cm2 RGD; data for 6 and
23 pmol/cm2 RGD is not shown, and data for 12 and
46 pmol/cm2 RGD is shown in Fig. 5b, c). Cell response to
soluble or immobilized EGF was the same for all levels of
EGF on low density, 12 pmol/cm2, RGD surfaces. At the
critical EGF level, the cells became smaller, rounder, and
with increasing EGF levels, detached from the surface.
3.5 Discussion
3.5.1 Cross-Talk Between RGD and EGF
in the Modulation of Cell Adhesion
Silane-PEG-biotin- modified surfaces enabled the selective
conjugation of biotinylated RGD and EGF molecules at a
controlled orientation, and with good accessibility, while
preventing non-specific binding of proteins from the extra-
cellular environment, and non-specific cell adhesion. The
densities obtained for surface-immobilized biotinylated
EGF were within the same range of densities published in
the literature for other EGF immobilization techniques [17,
18, 24, 44].
Cell adhesion experiments indicate that stimulation of
serum-starved A431 cells with EGF led to the formation of
FAs, in combination with cortical and cell-crossing actin
stress fibers, extensive filopodia, and actin-containing mi-
crospikes. These EGF-mediated cell adhesion responses
were found to be RGD- and EGF density- or EGF con-
centration-dependent (Figs. 3, 4, 5): EGF acted as an
adhesion stimulator up to a certain threshold level, above
which it behaved as an adhesion suppressor. This held true
for both immobilized and soluble EGF, and was highly
dependent on the RGD surface density (Figs. 4, 5).
It has been reported that intercellular contractile forces
are generated following EGF stimulation, through the
activation of myosin light chain (MLC; a subunit of myosin
II motor protein) promoting actin-myosin interaction either
through ERK/MAPK [6, 8] or through the activation of
PLCc [45] signaling pathways. Thus, the observed increase
in FA size and number may be required to sustain the
intercellular forces generated by EGF stimulation. Cells
plated on surfaces with low to medium densities of RGD
and treated with high amounts of EGF cannot sustain these
contractile forces, due to their lack of strong cell-surface
contact points; hence, their FAs disassemble, they round up
and detach from the surface.
The effect of EGF on the sensitivity of cell-adhesion
responses to RGD density is summarized in Figs. 2 and 4.
In the absence of EGF, cell spreading showed only minimal
changes in response to RGD densities above 23 pmol/cm2
(Fig. 2). However, a significant increase in the number of
FAs was observed in response to 1 ng/ml EGF, as the RGD
density was increased from 6 to 184 pmol/cm2 (Fig. 4).
Moreover, cells remained attached to 23, 46, 92 and
184 pmol/cm2 RGD surfaces upon stimulation with 10 ng/ml
EGF, but when stimulated with 100 ng/ml EGF, only cells
plated on 92 and 184 pmol/cm2 RGD surfaces remained
(Fig. 4). This indicates that the minimum RGD density
required for complete cell spreading in the absence of EGF is
lower than that required for the formation of stable cell–
matrix contacts following EGF stimulation.
3.5.2 Soluble Versus Immobilized EGF Stimulation
Our results show that the cell adhesion response to EGFR
stimulation is significant only at a critical EGF level, above
which cellular response to immobilized (local) EGF is
more pronounced than to soluble (global) stimulation. The
following section addresses the possible reasons for this
behavior.
Presentation of a ligand on a surface, such as that coated
with immobilized EGF, introduces better control over
ligand conformation, availability and density. Cell stimu-
lation with soluble ligands is dependent on the diffusion
potential of the ligand, and the probability that it reaches
the receptor in the appropriate conformation. Hence,
stimulation with immobilized ligands may be more
effective.
In addition, the binding of soluble EGF to EGFR under
physiological conditions is accompanied by the internali-
zation of the EGFR-EGF complex. This mechanism is used
by the cell to regulate EGF stimulation [46]. However, the
complex formed between an EGFR and immobilized EGF
cannot be internalized, thereby inducing ongoing cell
stimulation [47, 48], which may lead to constant, long-
lasting cellular contractile forces (see third paragraph of the
‘‘3.5’’). Our results may imply that, at the EGF level, at
which the cells are near the point of detachment, higher
numbers of FAs with greater aspect ratios are needed to
balance these contractile forces, than are needed to balance
potentially intermittent contractile forces induced by sol-
uble EGF. This view is supported by the observed cyto-
skeletal changes, which are also consistent with an
additional response to force. At a still higher immobilized-
EGF density, cells can no longer withstand these contrac-
tile forces, and they detach from the surface.
Still, a question remains regarding the presence of a
specific critical EGF threshold level, which induces sig-
nificant changes in cell adhesion behaviors. This can be
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explained in terms of the lateral EGF–EGF distance in an
EGFR dimer. According to crystal structure analysis, the
distance between EGF molecules in dimerized doubly
occupied EGFRs is 7.9 nm [49]. EGFR dimerization under
physiological conditions follows the binding of EGF to its
receptor, concomitant with the receptor’s transformation
from an inactive monomeric form to an active homodimer
form, leading to the initiation of the EGF signaling cascade
[18–20]. Low–EGF density surfaces correspond to average
EGF–EGF spacings, which are 3–7 times larger than that of
EGF molecules in doubly EGF-occupied EGFRs dimer,
hence in most cases would not induce EGFRs dimerization.
However, at the observed critical EGF surface density
3.8 ± 1.4 pmol/cm2 [(0.75 ± 0.28) 9 103 fmol], the
average spacing between each EGF molecule on the sur-
face is 6.8 ± 1.1 nm, enabling and maybe even forcing
EGF-occupied, monomeric EGFR to dimerize. This may
be the reason for the significant reduction in cell area and
polarity at the critical EGF density. Above the critical
density, at the same range of EGF–EGF spacing at a doubly
EGF- occupied EGFRs dimer, cellular response to immo-
bilized- EGF become by far more profound than that
obtained by soluble EGF, as manifested by the significant
increase in both the number of FAs per cell and in cell
spreading which was not observed upon stimulation with
the same level of soluble EGF (Fig. 5a, b). We note that the
values calculated for the spacings between the immobilized
EGF molecules are average values; a more precise
assessment of the effect of EGF spacing on the EGF-
mediated adhesion response could be achieved with hex-
agonally nanopatterned surfaces displaying a homogeneous
ligand distribution [1].
The co-immobilization of both EGF and RGD onto
the same surface potentially leads to the aggregation of
EGFRs in close proximity to integrins, and may thus
enhance EGFR-integrin cooperativity. The critical density
of immobilized EGF lies within the range of the RGD
density, suggesting a role for EGFR-integrin cooperativity
in EGF- mediated adhesion response. It has been sug-
gested that co-clustering of EGFR and integrins consti-
tutes a prerequisite for the co-clustering and synergism of
downstream signaling molecules [50, 51]. The enhanced
effect of immobilized EGF on cell adhesion, compared to
soluble EGF at these small ratios between integrin and
EGFR ligand densities, may imply that close proximity is
a requirement for direct integrin-EGFR cooperativity.
Ligand-mediated, activated integrin and EGFR have been
shown to cooperate through Src, inducing the activation of
Rac1 and the suppression of RhoA activity [16, 52, 53].
Rac1 activation results in lamellipodia and filopodia for-
mation, leading to cell spreading, and has also been
shown to precede cell detachment following FA disas-
sembly [52].
4 Summary and Conclusions
We have shown that there is a synergism in the cell adhesion
response between integrin and EGFR, in an RGD- and EGF
density- or concentration-dependent manner. Cell stimula-
tion with low to intermediate doses of EGF induces adhesion
activation, whereas high EGF doses suppress adhesion. The
effect of immobilized EGF differs from the effect of soluble
EGF above a certain EGF density. This may be because
surface presentation of the EGF ligand enables (1) more
precise control over ligand accessibility and density; (2) the
non-internalization of the receptor-ligand complex, hence
resulting in constant, ongoing cellular stimulation; (3) the
close proximity of the EGF and RGD ligands, which may
‘‘force’’ the integrins and EGFRs to aggregate. The critical
EGF density is the one most likely required for the induction
of EGFR dimerization, and lies within the range of the RGD
density, suggesting a role for EGFR-integrin cooperativity
in EGF- mediated adhesion response.
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